U-47700 solution

U-47700 is a highly potent opioid analgesic drug that has been confirmed in many opioid overdoses and deaths and was found in combination with fentanyl during the autopsy of the American guitarist Prince in 2016. U-47700 is regulated as a Schedule I compound in the United States. This Certified Spiking Solution^® is applicable for use in urine drug testing, clinical toxicology, or forensic analysis applications by LC-MS/MS or GC/MS.

This Cerilliant product is part of the Centers for Disease Control and Prevention (CDC) Opioid CRM Kit including more than 40 CRMs to be used as part of CDC′s laboratory response to the opioid epidemic. The kits are provided free of charge to drug testing laboratories located in the United States. A requesting lab must have current DEA registration and must comply with all respective state and local regulations. Visit www.cerilliant.com for instructions on requesting a free Opioid CRM Kit. Please note, CDC will review and approve all order requests prior to shipment.

German
Dieses Produkt fällt unter das Betäubungsmittelgesetz (BtMG). Für eine Bestellung dieses Produktes ist eine Erlaubnis nach § 3 BtMG zwingend erforderlich, es sei denn, es greift eine Ausnahme von der Erlaubnispflicht nach § 4 oder § 26 BtMG.

English
This product is subject to the German Narcotics Act. A permit under Section 3 of the German Narcotics Act is mandatory for ordering this product unless an exemption from the permit requirement under Section 4 or Section 26 of the German Narcotics Act applies.

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Supply conditions do not apply to the regions and states of Brazil: North, Northeast, Mato Grosso do Sul, Mato Grosso, and Rio Grande do Sul.